THE TRANSFORM STUDY: LOWER VIRAL INFECTIONS WITH EVEROLIMUS AND REDUCED CALCINEURIN INHIBITOR VERSUS MYCOPHENOLATE AND STANDARD CALCINEURIN INHIBITOR IN DE NOVO KIDNEY TRANSPLANT PATIENTS AT MONTH 12

MLA

Buchler, M., et al. The Transform Study: Lower Viral Infections with Everolimus and Reduced Calcineurin Inhibitor Versus Mycophenolate and Standard Calcineurin Inhibitor in De Novo Kidney Transplant Patients at Month 12. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..3869a827ad61c6ed3c1b6221f2eb07da&authtype=sso&custid=ns315887. Accessed 29 Jan. 2025.

APA

Buchler, M., Sommerer, C., Mulgaonkar, S., Garcia, V., Massari, P., Dirk RJ Kuypers, Citterio, F., Vincenti, F., Luo, W. L., Bernhardt, P., & Cruzado, J. (n.d.). The Transform Study: Lower Viral Infections with Everolimus and Reduced Calcineurin Inhibitor Versus Mycophenolate and Standard Calcineurin Inhibitor in De Novo Kidney Transplant Patients at Month 12.

Chicago

Buchler, M., C. Sommerer, S. Mulgaonkar, V. Garcia, P. Massari, Dirk RJ Kuypers, F. Citterio, et al. 2025. “The Transform Study: Lower Viral Infections with Everolimus and Reduced Calcineurin Inhibitor Versus Mycophenolate and Standard Calcineurin Inhibitor in De Novo Kidney Transplant Patients at Month 12.” Accessed January 29. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..3869a827ad61c6ed3c1b6221f2eb07da&authtype=sso&custid=ns315887.